Physician

Pathology

Zachary D. Goodman is an expert in the field of Pathology. He went to Vanderbilt University School of Medicine. Zachary Goodman is a published physician. He has 41 publications published. The most current publication "Epidemiology and natural history of non-alcoholic fatty liver disease." Zachary D. Goodman, MD accepts all Medicare patients.

Publications

---

• Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.
• Anti-Adipocyte Antibody Response in Patients with Non Alcoholic Fatty Liver Disease.
• Correlates of Adiponectin in Hepatitis C Infected Children: The Importance of Body Mass Index.
• A Single Non-invasive Model to Diagnose Non-alcoholic Fatty Liver Disease (NAFLD)and Non-alcoholic Steatohepatitis (NASH).
• Adipocytokine Expression Associated with miRNA Regulation and Diagnosis of NASH in Obese Patients with NAFLD.
• The impact of obesity on liver histology.
• Pathology Of The Liver Sinusoids.
• Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
• Liver disease after intensive care of premature baboons: histopathologic observations.
• Commentary: phlebotomy in non-alcoholic fatty liver disease.
• Expression of genes for miRNAs-processing enzymes is altered in advanced non-alcoholic fatty liver disease (NAFLD).
• Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C- a retrospective study.
• Improvement in liver histology among Asian patients with chronic hepatitis B after long-term treatment with entecavir.
• Genetics and imaging of hepatocellular adenomas: 2011 update. Invited commentary.
• Segmental atrophy of the liver: a distinctive pseudotumor of the liver with variable histologic appearances.
• Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients.
• Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.
• An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
• Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
• Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.
• Calcifying nested stromal-epithelial tumors of the liver: a clinicopathologic, immunohistochemical, and molecular genetic study of 9 cases with a long-term follow-up.
• Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma.
• Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
• Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
• Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma.
• Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms.
• Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases.
• Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis.
• Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or ...
• Neoplasms of the liver.
• Pathologic assessment of non-alcoholic fatty liver disease.
• Giant cell tumor of the extrahepatic biliary tree: a clinicopathologic study of 4 cases and comparison with anaplastic spindle and giant cell carcinoma with osteoclast...
• Diabetic hepatosclerosis: diabetic microangiopathy of the liver.
• Diagnosis of focal nodular hyperplasia of the liver by needle biopsy.
• More severe parenchymal injury in chronic hepatitis C acquired by recent injection drug use.
• Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
• Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers.
• Idiopathic adulthood ductopenia associated with hepatitis C virus.
• Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
• Epidemiology and natural history of non-alcoholic fatty liver disease.

Doctors Specialties

---

• Anatomic Pathology
• Pathology

Accepted Insurances

---

Education

---

• Johns Hopkins University
• Vanderbilt University School of Medicine

Hospital

---

• Inova Mount Vernon Hospital
• Inova Fairfax Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Rui He, MD This Doctor is OpenDoctor Recommended.
	Dr. Leslie H. Sobin, MD This Doctor is OpenDoctor Recommended.
	Dr. Geetha A. Menezes, MD This Doctor is OpenDoctor Recommended.
	Dr. Barrett B. Brown, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles J. Bechert, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog